Last update 04 Jul 2025

LRRK2 G2019S inhibitors 13(Emory University)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
LRRK2 G2019S
Action
inhibitors
Mechanism
LRRK2 G2019S inhibitors(LRRK2 G2019S inhibitors)
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic Disease
Active Indication
Alzheimer DiseaseParkinson Disease
Inactive Indication-
Originator Organization
Emory UniversityEmory University
Active Organization
Emory UniversityEmory University
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC23H29N5O
InChIKeyOXKGTOAHTYULQD-IVGNWBEBSA-N
CAS Registry3054889-69-6

Related

100 Clinical Results associated with LRRK2 G2019S inhibitors 13(Emory University)
Login to view more data
100 Translational Medicine associated with LRRK2 G2019S inhibitors 13(Emory University)
Login to view more data
100 Patents (Medical) associated with LRRK2 G2019S inhibitors 13(Emory University)
Login to view more data
1
Literatures (Medical) associated with LRRK2 G2019S inhibitors 13(Emory University)
13 Mar 2025ACS Medicinal Chemistry Letters
Identification of Indazole- and Azaindazole-Substituted Cyclopentapyrroles as G2019S Leucine-Rich Repeat Kinase 2 Inhibitors for the Treatment of CNS Disorders
100 Deals associated with LRRK2 G2019S inhibitors 13(Emory University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseaseDiscovery
United States
Emory UniversityEmory University
13 Feb 2025
Parkinson DiseaseDiscovery
United States
Emory UniversityEmory University
13 Feb 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free